Fellowship in Population Health Research

Goal of the Fellowship

To improve primary care quality and reduce health disparities by preparing a cadre of well trained primary care research faculty for careers with a focus on underserved populations

Despite leading the world in health care spending, the United States ranks near the bottom when critical health outcomes are compared with other countries. Many of these outcomes result from failures in primary care delivery, leading to a heavy burden of preventable morbidity, disability, mortality and suffering of our most vulnerable populations. We miss opportunities to translate and scale up advances in biomedical science into improvements in practice and health. This failure to translate evidence into practice is notable in all areas of the health care system, but disproportionately impacts urban, poor, minority populations. High quality research in how to apply proven strategies to large and diverse populations is in short supply and remains vital to the public’s health. The Fellowship in Population Health Research at NYU School of Medicine has been designed to train a cadre of physician-leaders to meet this challenge.

Led by an outstanding interdisciplinary team of academic generalist physicians, the two-year fellowship is designed for physicians interested in careers in population-based, patient-centered primary care research with a focus on improving the health of medically underserved populations, improving the quality of primary care, and enhancing access to care. The two year fellowship is supported by a National Research Services Award (NRSA, T32) from the Health Resources and Services Administration (HRSA). NYU School of Medicine will award a Master of Science Degree in Clinical Investigation to fellows successfully completing the program requirements.

Each Fellow will receive a stipend, full tuition, health insurance, books, travel, and related program expenses. A Master of Science in Clinical Investigation is awarded upon successful program completion.

Program Director: Mark D. Schwartz, MD Principal Investigator: Arthur Fierman, MD